LITTLE FALLS, N.J., Dec. 19, 2018 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) announced today that its Board of Directors approved an increase in its semiannual cash dividend from $0.085 to $0.10 per outstanding share of the Company's Common Stock. The dividend is payable on January 31, 2019 to shareholders of record at the close of business on January 17, 2019.
"We are pleased to announce the increase in our dividend, which will raise our annual payment from $0.17 to $0.20 per share. This is the 9th consecutive year that we have increased our dividend. The 17.6% increase is a direct result of record sales and strong earnings performance and demonstrates our confidence in the future success of Cantel," stated Charles M. Diker, Chairman of the Board. "We remain committed to enhancing value for our shareholders and the dividend is an important component."
Cantel Medical is a leading global company dedicated to delivering innovative infection prevention products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products. Additionally, we provide technical service for our products.
For further information, visit the Cantel website at www.cantelmedical.com.
SOURCE Cantel Medical Corp.